Financial Disclosure Statement

MSACL 2018 US Abstract Title:
Proteometabolomics of Myeloma Drug Resistance
David Koomen
Moffitt Cancer Center

DescriptionY/NSource
Grantsno
Salaryno
Board Memberno
Stockno
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no